<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02759926</url>
  </required_header>
  <id_info>
    <org_study_id>BitterMotilityHungerFoodIntake</org_study_id>
    <nct_id>NCT02759926</nct_id>
  </id_info>
  <brief_title>The Effect of Bitter Taste Receptor Agonists on The Gastrointestinal Tract, Hunger and Food Intake</brief_title>
  <official_title>The Role of Bitter Taste Receptors Expressed in the Gastrointestinal Tract in Altering Food Intake and Gastrointestinal Motility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators aimed at evaluating the role of bitter taste receptors in
      the gastrointestinal tract (GIT). Intragastric or intraduodenal administration of denatonium
      benzoate (DB) or quinine hydrochloride were compared with placebo administration for their
      effects on lingual sensitivity, gastrointestinal motility (both in the fasted and fed state),
      gut hormone release (motilin, ghrelin, glucagon-like peptide-1 (GLP-1) and cholecystokinin
      (CCK)) and food intake. Differences between lean and obese subjects will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in gastrointestinal motility measured by antroduodenal high-resolution manometry</measure>
    <time_frame>2 hours after administration, continuous measurement with high resolution manometry</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in gut hormone release measured by specific radioactive immunoassays</measure>
    <time_frame>2 hours after administration, blood sample every 10 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in food intake measured by the caloric content of the meal</measure>
    <time_frame>ad libitum food intake for 1 hour, 40 min after administration</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in subjective hunger and satiety scores measured by visual analogue scales of 100 mm</measure>
    <time_frame>2 hours after administration, assessment every 5 min</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Healthy</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Denatonium benzoate intragastric</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 µmol/kg bodyweight (10mM) was administered as a bolus into the stomach through a nasogastric feeding tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quinine hydrochloride intragastric</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 µmol/kg bodyweight (100mM) was administered as a bolus into the stomach through a nasogastric feeding tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tap water intragastric</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>An equal amount of tap water was administered as a bolus into the stomach through a nasogastric feeding tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Denatonium benzoate intraduodenal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 µmol/kg bodyweight (10mM) was administered as a bolus into the proximal part of the duodenum through a nasogastric feeding tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quinine hydrochloride intraduodenal</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 µmol/kg bodyweight (100mM) was administered as a bolus into the proximal part of the duodenum through a nasogastric feeding tube.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tap water intraduodenal</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>An equal amount of tap water was administered as a bolus into the proximal part of the duodenum through a nasogastric feeding tube.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Denatonium benzoate</intervention_name>
    <arm_group_label>Denatonium benzoate intragastric</arm_group_label>
    <arm_group_label>Denatonium benzoate intraduodenal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Quinine hydrochloride</intervention_name>
    <arm_group_label>Quinine hydrochloride intragastric</arm_group_label>
    <arm_group_label>Quinine hydrochloride intraduodenal</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tap water</intervention_name>
    <arm_group_label>Tap water intragastric</arm_group_label>
    <arm_group_label>Tap water intraduodenal</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI&gt;30 kg/m² for the obese volunteers

          -  BMI&lt;30 kg/m² for the lean volunteers

          -  Subject is capable and willing to give informed consent

          -  Female volunteers of child bearing potential must use oral, injected or implanted
             hormonal methods of contraception

        Exclusion Criteria:

          -  Female volunteer is pregnant or breastfeeding

          -  Gastrointestinal diseases, major abdominal surgery

          -  Major psychiatric illnesses

          -  Volunteers that use drugs affecting the GIT or the central nervous system (CNS)

          -  Volunteers that suffer from diabetes mellitus

          -  Volunteers suffering from an endocrine disease such as diabetes, Cushing's disease,
             Addison's disease, hypothalamic tumor…

          -  Volunteers that have undergone surgical procedure for weight loss
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Tack, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitaire Ziekenhuizen Leuven</affiliation>
  </overall_official>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2016</study_first_submitted>
  <study_first_submitted_qc>April 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 3, 2016</study_first_posted>
  <last_update_submitted>April 29, 2016</last_update_submitted>
  <last_update_submitted_qc>April 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy volunteers</keyword>
  <keyword>Obesity</keyword>
  <keyword>Bitter</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quinine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

